Advanced search
Publication Cover
International Journal of Chronic Obstructive Pulmonary Disease Volume 13, 2018 - Issue
Submit an article Journal homepage
79
Views
16
CrossRef citations to date
0
Altmetric
Original Research

Use of a 4-week up-titration regimen of roflumilast in patients with severe COPD

Henrik Watz1 Pulmonary Research Institute at LungenClinic Grosshansdorf, Airway Research Center North, German Center for Lung Research, Grosshansdorf, GermanyCorrespondence[email protected]
,
Nitin Bagul2 DNA Medical Ltd, Langley, UK
,
Klaus F Rabe3 Department of Pulmonary Medicine, LungenClinic Grosshansdorf, Airway Research Center North, German Center for Lung Research, Grosshansdorf;4 Department of Medicine, Christian Albrecht University Kiel, Kiel, Germany
,
Stephen Rennard5 Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, USA;6 AstraZeneca, Cambridge, UK
,
Vijay KT Alagappan7 AstraZeneca, Gaithersburg, MD, USA
,
Jonas Román8 AstraZeneca R&D, Gothenburg, Sweden
,
Axel Facius9 thinkQ2 AG, Baar, Switzerland
&
Peter MA Calverley10 Department of Clinical Sciences, Institute of Ageing and Chronic Disease, University of Liverpool, Liverpool, UK
 show all
Pages 813-822 | Published online: 06 Mar 2018

Citations (16)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Tai Sun Park, Jieun Kang, Jae Seung Lee, Yeon-Mok Oh, Sang-Do Lee & Sei Won Lee. (2019) Adherence to roflumilast under dose-escalation strategy in Korean patients with COPD. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 871-879.
Read now
J. Alberto Neder, Alcides Rocha, Maria Clara N. Alencar, Flavio Arbex, Danilo C. Berton, Mayron F. Oliveira, Priscila A. Sperandio, Luiz E. Nery & Denis E. O’Donnell. (2018) Current challenges in managing comorbid heart failure and COPD. Expert Review of Cardiovascular Therapy 16:9, pages 653-673.
Read now
Peter Kardos, Ingo Mokros, Rüdiger Sauer & Claus F Vogelmeier. (2018) Health status in patients with COPD treated with roflumilast: two large noninterventional real-life studies: DINO and DACOTA. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 1455-1468.
Read now

Articles from other publishers (13)

Yazdan Hasani Nourian, Jafar Salimian, Ali Ahmadi, Zahra Salehi, Mehrdad Karimi, Alireza Emamvirdizadeh, Sadegh Azimzadeh Jamalkandi & Mostafa Ghanei. (2023) cAMP-PDE signaling in COPD: Review of cellular, molecular and clinical features. Biochemistry and Biophysics Reports 34, pages 101438.
Crossref
Dennis Williams. (2020) The Role of the Pharmacist in Optimizing Outcomes With Roflumilast, a PDE4 Inhibitor for the Treatment of COPD. Journal of Pharmacy Practice 35:3, pages 445-454.
Crossref
Sumbal Naseem, Muhammad Hassan, Shazia Nasim Akhtar, Fibhaa Syed, Naveed Ullah Khan & Muhammad Usman. (2022) Effectiveness of Roflumilast in Treating Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis. Cureus.
Crossref
Dave Singh. 2022. Encyclopedia of Respiratory Medicine. Encyclopedia of Respiratory Medicine 741 753 .
Dave Singh, Simon Lea & Alexander G. Mathioudakis. (2021) Inhaled Phosphodiesterase Inhibitors for the Treatment of Chronic Obstructive Pulmonary Disease. Drugs 81:16, pages 1821-1830.
Crossref
Theerasuk Kawamatawong. (2021) Phosphodiesterase-4 Inhibitors for Non-COPD Respiratory Diseases. Frontiers in Pharmacology 12.
Crossref
Dave Singh. (2021) Pharmacological treatment of stable chronic obstructive pulmonary disease. Respirology 26:7, pages 643-651.
Crossref
Dave Singh, Fernando J. Martinez, Henrik Watz, Thomas Bengtsson & Brian T. Maurer. (2020) A dose-ranging study of the inhaled dual phosphodiesterase 3 and 4 inhibitor ensifentrine in COPD. Respiratory Research 21:1.
Crossref
Imane Achir Alispahic, Rikke Sørensen, Josefin Eklöf, Pradeesh Sivapalan, Anders Løkke, Niels Seersholm, Jakob Hedemark Vestergaard & Jens-Ulrik Stæhr Jensen. (2020) Roflumilast in Severely Ill Patients with Chronic Obstructive Pulmonary Disease with Frequent Exacerbations: Risk of Pneumonia Hospitalization and Severe Exacerbations. Journal of Clinical Medicine 9:5, pages 1442.
Crossref
Sadia Janjua, Rebecca Fortescue & Phillippa Poole. (2020) Phosphodiesterase-4 inhibitors for chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2020:5.
Crossref
Chin Kook Rhee & Deog Kyeom Kim. (2020) Role of phosphodiesterase-4 inhibitors in chronic obstructive pulmonary disease. The Korean Journal of Internal Medicine 35:2, pages 276-283.
Crossref
Dinesh Yogaratnam, Mary Bylo, Katherine M. Carey, Valerie Coppenrath, Aimee Dawson, Amy B.W. LaMothe, Ann M. Lynch & Nnamdi Okeke. 2019. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions 171 182 .
Axel Facius, Eleonora Marostica, Philip Gardiner, Henrik Watz & Gezim Lahu. (2018) Pharmacokinetic and Pharmacodynamic Modelling to Characterize the Tolerability of Alternative Up-Titration Regimens of Roflumilast in Patients with Chronic Obstructive Pulmonary Disease. Clinical Pharmacokinetics 57:8, pages 1029-1038.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.